Treatment is always focused on the specifi c patient involved, meaning that the method and the
electric fi eld are specifi cally adjusted to the patient. Nanothermia supports natural processes
of the human body (including apoptosis, immune system response …). It is complementary
to accepted conventional oncological treatment methods, it can be combined with all types of
chemotherapy and radiation therapy and it can support the pre- and post-operative phases of
surgical treatment. Nanothermia presents no risks for the patient. On the contrary: patients
tend to fi nd the treatment even pleasant. Nanothermia is not intended to serve as a sole cancer
therapy, however. It is closely oriented to conventional medical treatment and should be used in
a supporting role with such treatment. Studies have shown that a combination of Nanothermia and radiation or chemotherapy can be highly effective, and that Nanothermia strongly enhances
the effects of such other treatments. Nanothermia .
Nanothermia in combination with mytomycin-C
A combination of Nanothermia treatments and mytomycin-C chemotherapy can sharply increase cell-death rates, by to up to 66.1%. This implies that Nanothermia boosts the effects of chemotherapy and can enhance the results obtained at the cellular level. While conventional Hyperthermia also improves the effects at the cellular level, its improvement rate, at 7.7%, is much lower than that provided by
Nanothermia in combination with radiation therapy
Depending on the tumor’s blood-perfusion status, Nanothermia treatment is applied either prior to or after
the ionizing radiation. With low blood perfusion, the aim is
to increase the oxygen content of the blood, to support the
therapy‘s ionization effect. That end calls for the Nanothermia treatment to use a low energy dose. In case of high blood perfusion, radiation is normally expected to be highly effective. For best results,
Nanothermia treatments following radiation must provide the maximum possible (tolerable) energy dose.
Nanothermia in combination with mytomycin-C
A combination of Nanothermia treatments and mytomycin-C chemotherapy can sharply increase cell-death rates, by to up to 66.1%. This implies that Nanothermia boosts the effects of chemotherapy and can enhance the results obtained at the cellular level. While conventional Hyperthermia also improves the effects at the cellular level, its improvement rate, at 7.7%, is much lower than that provided by
Nanothermia treatments following radiation must provide the maximum possible (tolerable) energy dose.
Nanothermia and surgery
Nanothermia treatment for patients with inoperable rectal carcinoma. After treatment, 71% of the patients were operable (Prof. H. Renner, Hyperthermia Symposium, Cologne, October 2003)